BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1118816)

  • 1. [Mechanism of action of clofibrate].
    Lang PD
    Ther Ggw; 1975 Feb; 114(2):204-6, 208-10, 212-4. PubMed ID: 1118816
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
    Kritchevsky D; Tepper SA
    Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of p-chlorophenoxyisobutyric acid on adipose tissue metabolism].
    Giocoli G
    Ann Ist Super Sanita; 1971; 7(4):513-24. PubMed ID: 4402757
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of clofibrate on cholesterol and lipid metabolism in ethanol - treated mice.
    Rawat AK
    Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):501-10. PubMed ID: 1135514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of clofibrate on fatty acid desaturation of rats treated with ethanol.
    Peluffo RO; Nervi AM; Brenner RR
    Acta Physiol Lat Am; 1981; 31(2):119-28. PubMed ID: 6821269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of action of drugs affecting lipid metabolism].
    Rossini L
    Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects on lipid metabolism of inhibitors of cholesterol synthesis].
    Guarini G; Costa C; Trimarco C; Santese D; Vitaliano E
    Clin Ter; 1988 Apr; 125(1):41-50. PubMed ID: 2974357
    [No Abstract]   [Full Text] [Related]  

  • 10. The application of a simple method to determine the mode of action of oral antihypercholesteremic drugs.
    Brandau K; Schlossmann K
    Arzneimittelforschung; 1974 Oct; 24(10):1535-42. PubMed ID: 4479759
    [No Abstract]   [Full Text] [Related]  

  • 11. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
    Azarnoff DL; Svoboda DJ
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of hycholesteremic substances on the lipid composition of the organs of rats fed a high-fat diet].
    Amici G; Franzini D; Samaja U
    Minerva Med; 1966 Dec; 57(96):4056-64. PubMed ID: 6006017
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
    White LW
    J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of Atromid-S and high-fat diet on lipids and lipolysis in rat tissues and serum].
    Grafnetter D; Mrhová O; Janda J
    Cas Lek Cesk; 1970 May; 109(20):433-9. PubMed ID: 5429476
    [No Abstract]   [Full Text] [Related]  

  • 15. Saturated free fatty acid toxicity. III. Potentiation by chlorophenoxyisobutyrate (clofibrate) in strain L cells.
    Gordon GB
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):79-99. PubMed ID: 566458
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of studies on the mode of action of clofibrate and betabenzalbutyrate.
    Fallon HJ; Adams LL; Lamb RG
    Lipids; 1972 Feb; 7(2):106-9. PubMed ID: 4551948
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Tomita T; Takeshita R; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proliferation inhibition and lipid accumulation in cell cultures with clofibrinic acid (Regadrin)].
    Jakob W; Mauersberger B; Krieg K; Minenko A
    Pharmazie; 1977 Dec; 32(12):798-800. PubMed ID: 613323
    [No Abstract]   [Full Text] [Related]  

  • 19. Newer hypolipidemic agents.
    Kritchevsky D
    Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats. II. Comparative action of clofibrate and tiadenol on biliary and fecal excretion of cholesterol and its metabolites in rats].
    Fredj G; Clenet M; Rousselet F
    Ann Pharm Fr; 1986; 44(5):347-54. PubMed ID: 3579157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.